Propranolol and Amitriptyline in Prophylaxis of Migraine: Pharmacokinetic and Therapeutic Effects

Archives of Neurology

Volumn 50, Issue 8, 1993, Pages 825-830

  Ziegler, Dewey K ^a   Hurwitz, Aryeh ^a   Preskorn, Sheldon ^a   Hassanein, Ruth ^a   Seim, Judy ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; PLACEBO; PROPRANOLOL;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISCRIMINANT ANALYSIS; DRUG BLOOD LEVEL; DRUG RESPONSE; HUMAN; MIGRAINE; PRIORITY JOURNAL; PULSE RATE; RANDOMIZATION; SALIVATION; SCORING SYSTEM; SEX DIFFERENCE;

ADOLESCENT; ADULT; AMITRIPTYLINE; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGE; MIGRAINE; PAIN MEASUREMENT; PROPRANOLOL; PULSE; SALIVA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027275207     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1993.00540080036010     Document Type: Article

References (39)

1. Ad Hoc Committee on Classification of Headache, American Academy of Neurology. A classification of headache. Neurology. 1962;12:378-380.
2. Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskorn SH, Mason J. Migraine prophylaxis: a comparison of propranolol and amitriptyline. Arch Neurol. 1987;44:486-489.
3. Myers MG, Freeman MR, Tuma ZA, Wisenberg G. Propranolol in angina pectoris: a prospective study. Am Heart J. 1979;97:298-302.
4. MacKichan JJ, Pyszczynski DR, Jusko WJ. Analysis and disposition of low dose oral propranolol. Res Commun Chem Pathol Pharmacol. 1978;20: 531-538.
5. Mellstrom B, Braithwaite R. Ion-pair liquid chromatography of amitriptyline and metabolites in plasma. J Chromatogr. 1978;157:379.
6. Serlin MJ, Orme MLE, Baber NS, Sibeon RG, Laws E, Breckenridge A. Propranolol in the control of blood pressure: a dose-response study. Clin Pharmacol Ther. 1980;27:586-592.
7. Kaye MD, Rhodes J, Sweetnam PM. Clinical evaluation of three longacting anticholinergic compounds. Gut. 1968;9:590-596.
8. Morrison DF. Multivariate Statistical Methods. 2nd ed. New York, NY: McGraw-Hill International Book Co; 1976.
9. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York, NY: McGraw-Hill International Book Co; 1971.
10. Routledge PA, Shand DG. Clinical pharmacokinetics of propranolol. Clin Pharmacokinet. 1979;4:73-90.
11. Kuritzky A, Ziegler DK, Hassanein R, Sood P, Hurwitz A. Relation between plasma concentration of propranolol, beta-blocking and migraine. In: Rose C, ed. Migraine, Proceedings of the Fifth International Migraine Symposium. Basel, Switzerland: S Karger AG; 1985:250-255.
12. Gengo FM, Fagan SC, Kinkel WR, McHugh WB. Serum concentrations of propranolol and migraine prophylaxis. Arch Neurol. 1984;41:1306-1307.
13. Gengo FM, Ulatowski JA, McHugh WB, et al. Metoprolol and alphahydroxymetoprolol concentrations and reduction in essential tremor. Clin Pharmacol Ther. 1984;36:320-325.
14. Jefferson D, Jenner P, Marsden CD. Relationship between plasma propranolol and relief of essential tremor. J Neurol Neurosurg Psychiatry. 1979;42:831-837.
15. Pine M, Favrot L, Smith S, McDonald K, Chidsey CA. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris. Circulation. 1975;52:886-893.
16. Preskorn HS, Fast GA. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J Clin Psychiatry. 1991;52:23-33.
17. Robinson DS, Cooper TB, Ravaris CL, et al. Plasma tricyclic drug levels in amitriptyline-treated depressed patients. Psychopharmacology. 1979; 63:223-231.
18. Mendlewicz J, Linkowski P, Rees JA. A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: serum levels and response. Br J Psychiatry. 1980;136:154-160.
19. Corona GL, Cucchi ML, Frattini P, et al. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression. Psychopharmacology. 1990;100:334-338.
20. Breyer-Pfaff U, Gaertner HJ, Krueter F, et al. Antidepressant effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxy-nortriptyline plasma levels. Psychopharmacology. 1982;76:240-244.
21. Watson LP, Evans RJ, Reed K, Merskey H, Goldsmith L, Walsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32: 671-673.
22. Koella WP. CNS-related side-effects of beta-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol. 1985;28:55-63.
23. Suzman MM. The use of beta-adrenergic blockade with propranolol in anxiety syndromes. Postgrad Med J. 1971;47(suppl):104.
24. Tyrer PJ, Lader MH. Physiological responses to propranolol and diazepam in chronic anxiety. Br J Clin Pharmacol. 1974;1:387.
25. Stone WN, Gleser GC, Gottschalk LA. Anxiety and beta-adrenergic blockade. Arch Gen Psychiatry. 1973;24:620.
26. Shader RI, Good MI, Greenblatt DJ. Anxiety states and beta-adrenergic blockade. In: Klein DF, Gittleman-Klein R, eds. Progress in Psychiatric Drug Treatment, II. New York, NY: Brunner-Mazel Inc; 1976:509-528.
27. Couch JR, Hassanein RS. Platelet aggregability in migraine. Neurology. 1977;27:843-849.
28. Frishman WH, Weksler BB. Effects of β-adrenoreceptor blocking agents on platelet function. In: Frishman WH, ed. Clinical Pharmacology of the β-Adrenoreceptor Blocking Drugs. Norwalk, Conn: Appleton-Century-Crofts; 1989:273-299.
29. Winther K, Hedman C. Beta-adrenoceptor blockade, platelets, and rheologic factors. Cephalalgia. 1986;6(suppl 5):33-39.
30. Joseph R, Welch KMA. The platelet and migraine: a non-specific association. Headache. 1987;27:375-380.
31. Egbunike IG, Chaffee BJ. Antidepressants in the management of chronic pain syndromes. Pharmacotherapy. 1990;90:262-270.
32. Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979;36:695-699.
33. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry. 1990;47:849-853.
34. Breslau N, Davis GC, Andreski P. Migraine, psychiatric orders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37:11-23.
35. Havanka-Kanniainen H, Tolonen U, Myllylä VV. Autonomic dysfunction in migraine: a survey of 188 patients. Headache. 1988;28:465-470.
36. Rubin LS, Graham D, Pasker R, Calhoun C. Autonomic nervous system dysfunction in common migraine. Headache. 1985;25:40-48.
37. Boiardi A, Munari L, Milanesi I, Paggetta C, Lamperti E, Bussone G. Impaired cardiovascular reflexes in cluster headache and migraine patients: evidence for an autonomic dysfunction. Headache. 1988;24:417-422.
38. Gotoh F, Komatsumoto S, Araki N, Gomi S. Noradrenergic nervous activity in migraine. Arch Neurol. 1984;41:951-955.
39. Woods D, O'Connor PS, Fleming R. Episodic unilateral mydriasis and migraine. Am J Ophthalmol. 1984;98:229-234.